This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

University Of Utah Hospital Purchases IMRISNV

    -- Leading stroke facility to study patient benefits --

WINNIPEG, March 28 /PRNewswire/ - (NASDAQ: IMRS) (TSX: IM) -- IMRIS Inc. ("IMRIS" or the "Company") today announced the sale of IMRISNV to University of Utah Hospital in Salt Lake City, Utah.

IMRISNV will provide important new capabilities for clinicians at University of Utah Hospital's leading edge stroke center. IMRISNV combines the imaging modalities of MR and fluoroscopy in a fully integrated suite to assist clinicians in the diagnosis and treatment of stroke and other neurovascular disorders. The system permits a patient to be transitioned quickly and seamlessly between assessment, using MR imaging, and intervention, using fluoroscopy guidance without the need to transport the patient between imaging modalities. During and immediately after a procedure, new MR images can be taken to assess the effectiveness of the treatment and to determine if further intervention is required.

In addition to an interventional theatre for stroke and other neurovascular procedures, the system at University of Utah Hospital will also include adjoining rooms for neurosurgical and diagnostic imaging. The interventional theatre for treating stroke patients will feature an advanced bi-plane angiography system and a wide bore 3T MR scanner. The high-field MR scanner can be deployed into any of the three rooms in the IMRIS suite. When not in use for intra operative imaging, both the MR and fluoroscopic system are available for diagnostic use.

The University of Utah (U of U) has been designated a Stroke Center of Excellence by Chicago-based think tank NeuStrategy. The U of U Stroke Center's "Institute" level certification, which is the highest recognition possible, signifies use of the most advanced technology, dedicated care for stroke patients, specialty-trained physicians and staff, and focused research to improve stroke care and outcomes. The U of U Stroke Center is also a Joint Commission Certified Primary Stroke Center and has been recognized by the American Heart and Stroke Association as providing the highest level of care for the stroke patients with the "Get with the Guidelines Gold Plus Certification".

In conjunction with the installation of IMRISNV, University of Utah Hospital will be undertaking a study to assess the capabilities and benefits of the IMRISNV system. Under the direction of Dr. Steve Stevens, Professor and Chair of the Department of Radiology at the University of Utah, the study will track and evaluate how IMRISNV contributes to the Neuroscience team's management of stroke and to the outcomes of its patients.

"The impact an ischemic stroke has on a patient is currently directly correlated to the length of time from stroke onset to treatment," said Dr. Stevens. " With IMRISNV, we will have the ability to quickly and accurately assess the stroke patient's brain using MR imaging and if indicated immediately undertake an interventional procedure using fluoroscopic guidance to resolve the condition. We believe the availability of MR imaging and fluoroscopy together in a fully integrated interventional environment will allow us to significantly advance our ability to identify and appropriately treat patients who suffer an ischemic stroke independent of time of onset."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.99 0.00%
FB $99.54 0.00%
GOOG $678.11 0.00%
TSLA $148.25 0.00%
YHOO $26.82 0.00%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs